Morning Overview on MSN
Bacteria turn plastic bottles into L-DOPA, a Parkinson’s drug
Researchers at the University of Edinburgh are working on engineering bacteria to convert chemicals derived from waste ...
Breakthrough manufacturing process comes in preparation for upcoming commercial launch in Europe planned for later this year ...
From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...
The Brighterside of News on MSN
The plastic bottle that became a Parkinson's drug
Plastic waste is becoming an increasing problem, with 50 million tonnes of single-use plastic being produced each year. Plastics are used in the packaging of food and drinks. However, they usually do ...
WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to participate in its PreCheck pilot program, designed to boost domestic drug supply by speeding ...
Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and ...
For years, pharmaceutical scientists have sought to enhance bioavailability by transforming drugs from their crystalline state into more soluble, amorphous forms. Traditional methods like spray drying ...
Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...
Adam Kovalčík, age 19, innovated a cheaper, faster way to produce an antiviral drug. Galidesivir targets RNA viruses like COVID-19, Ebola, and Zika but hasn't completed clinical trials. Kovalčík won a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results